By Innovation Times Health Correspondent
Abu Dhabi, The United Arab Emirates has entered a groundbreaking phase in its fight against cancer with the introduction of an advanced chemotherapy pump system designed to target tumours directly and reduce damage to healthy tissues. This cutting-edge technology marks a new era in UAE cancer care, combining precision medicine, patient comfort, and treatment efficiency to enhance survival rates and quality of life.
The innovative chemo pump, now being rolled out in leading hospitals across Abu Dhabi and Dubai, delivers controlled doses of anti-cancer drugs directly to tumour sites, allowing doctors to personalize treatment plans with higher accuracy. Unlike traditional chemotherapy that circulates throughout the body, this system enables localized drug delivery, minimizing side effects such as fatigue, nausea, and immune suppression.
According to oncologists at Cleveland Clinic Abu Dhabi and Tawam Hospital, the new pump technology represents a significant leap forward in oncology care. “This is precision oncology in action,” said Dr. Aisha Al Mansoori, a leading Emirati cancer specialist. “By focusing treatment exactly where it’s needed, we can protect the patient’s overall health while improving tumour response rates.”
The UAE’s Ministry of Health and Prevention (MoHAP) has hailed the introduction as part of its broader National Cancer Control Plan, which aims to establish the Emirates as a regional hub for advanced cancer diagnosis, treatment, and research. The initiative aligns with the country’s Vision 2031 goals to enhance healthcare innovation, promote local expertise, and attract global medical partnerships.
The chemo pump technology is particularly beneficial for patients with liver, pancreatic, and colorectal cancers, where localized chemotherapy delivery can significantly reduce systemic toxicity. The pump can be implanted subcutaneously and programmed to release medication over days or weeks, depending on the patient’s clinical needs.
Experts say the innovation is not just a technological upgrade but a shift toward patient-centered cancer care. With reduced hospital stays, fewer complications, and improved recovery times, patients can maintain a higher quality of life while undergoing treatment. “This approach gives patients hope and control,” noted Dr. Rania Khalid, an oncology researcher in Dubai. “It allows them to fight cancer without losing their strength, dignity, or daily routines.”
The move also reflects the UAE’s growing investment in biomedical technology, precision medicine, and AI-driven diagnostics, fields that are rapidly transforming global healthcare. Partnerships with leading institutions in Europe and the United States have positioned the UAE as a leader in innovative cancer therapies within the Middle East.
As cancer incidence continues to rise worldwide, the UAE’s adoption of this smart chemotherapy delivery system underscores its commitment to early detection, advanced treatment, and holistic patient support. For patients and healthcare providers alike, the new chemo pump symbolizes more than just medical progress — it represents a promise of healing, precision, and a future where cancer treatment is safer and more effective.
